Efficacy of Point Of Service Testing in MBC
This study will assess the efficacy of an innovative point of service cancer genetics counseling delivery model for metastatic breast cancer (MBC) patients whom have received a referral for hereditary cancer genetic counseling and testing.
- Metastatic Cancer
- Breast Cancer
- Eligible Ages
- Over 18 Years
- Eligible Genders
- Accepts Healthy Volunteers
- Ability of participant OR Legally Authorized Representative (LAR) to understand this study, and participant or LAR willingness to sign a written informed consent. - Able to speak and read in the English language. - Have a diagnosis of human epidermal growth factor receptor 2 (HER2) negative metastatic breast cancer. - Participants must be enrolled in the parent registry study.
- Genetic testing for a breast cancer gene (BRCA) BRCA1 and BRCA2 mutation completed after 2013 or any BRCA 1 and BRCA2 testing with large rearrangement testing. Prior genetic counseling is allowed. - Psychiatric illness/social situations that would limit compliance with study requirements.
- Study Type
- Intervention Model
- Single Group Assignment
- Primary Purpose
- Health Services Research
- None (Open Label)
Point of service delivery model
|After the informed consent is signed, the participant will watch a standardized video on the principles of genetic testing. At the end of the video, the provider will return to answer any remaining questions. The participant will receive pre- and post- surveys for evaluation of the delivery model.||
- University of Kansas Medical Center
Study ContactCT Nurse Navigator